Atlas FDA

NWG

2 FDA 510(k) clearances · Product code

FDA profile

Official device name
Autoantibodies, Glutamic Acid Decarboxylase (Gad)
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5660
Medical specialty
Immunology
Flags
Third-party review eligible
FDA definition
The device is used for the semi-quantitative determination of glutamic acid decarboxylase (GAD) autoantibodies in human serum as an aid in the diagnosis of Type I diabetes mellitus (autoimmune mediated diabetes).
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
KRONUS GAD AUTOANTIBODY ELISA ASSAY KIT (K072135)Kronus Market Development Associates, Inc.2007-11-07
KRONUS GLUTAMIC ACID DECARBOXYLASE ANTIBODY KIT (K051061)Kronus Market Development Associates, Inc.2005-11-04

Track NWG automatically

Every clearance here is in the API, with alerts when new ones post.